Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B‐cell lymphoma: Insights from real‐life clinical practice

Authors: Jasmine Mohamad, Antonin Bouroumeau, Thomas A. McKee, Nicolas Mach, Kaveh Samii, Martine Chamuleau, Frank Stenner, Jerome Tamburini, Noémie Lang

Source: Cancer Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)

Subject Terms: aggressive B lymphoma, rituximab, tumor lysis syndrome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2573-8348

Access URL: https://doaj.org/article/cf0a78b3ca2d44d5893e8e7e4da2071b

PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYMPHOMA

Authors: Jason Westin, Caron Jacobson, Julio C Chavez, Anna Sureda, Franck Morschhauser, Bertram Glass, Michael Dickinson, Andrew J. Davies, Ian W. Flinn, David Maloney, Martine Chamuleau, Michael Tees, Allen Xue, Shilpa Shahani, Olga Nikolajeva, Janet Kang, Aida Kaplan, Marco Schupp, Harry Miao, Elizabeth Shima Rich

Source: HemaSphere, Vol 7, p e3278692 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000975996.32786.92; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/f25c7cb01f0949d49598ffa2e49b37f6

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS

Authors: Carolien Maas, David van Klaveren, Mujde Durmaz, Otto Visser, Djamila Issa, Eduardus F.M. Posthuma, Josée Zijlstra, Martine Chamuleau, Pieternella Lugtenburg, Marie José Kersten, Avinash Dinmohamed

Source: HemaSphere, Vol 7, p e80376cd (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000971452.80376.cd; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/6b2a2831d59c496f8278d23e27d8259c

HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma

Authors: Wendy B.C. Stevens, Katerina Bakunina, Marloes Cuijpers, Martine Chamuleau, Aart Beeker, Rob Fijnheer, Holger Hebart, Hein P.J. Visser, Jeanette K. Doorduijn, Kim Linton, Martin Dreyling, Daphne de Jong, Marie José Kersten

Source: HemaSphere, Vol 4, Iss 1, p e325 (2020)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/HS9.0000000000000325; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/23ca07bf9b364b99a59d448aead35389